Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

Genetics: Counseling, Testing, and Diagnosis (Vol XV, No 2)

For information on carrier screening for genetic conditions, refer to Carrier screening for genetic conditions. Committee Opinion No. 691. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e41-55

For information on carrier screening in the age of genomic medicine, refer to Carrier screening in the age of genomic medicine. Committee Opinion No. 690. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e35-40

For more information on microarrays and next-generation sequencing technology, refer to Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Committee Opinion No. 682. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e262-8.

For various resources on genetics and genomics compiled by the American College of Obstetrician and Gynecologist's Resource Center refer to: http://www.acog.org/About-ACOG/ACOG-Departments/Resource-Center/WEBTREATS-Genetics-Genomics

Below is the current list of genetics-related guidelines developed by the American College of Obstetricians and Gynecologists:

Genetics and Molecular Diagnostic Testing (Technology Assessment No. 11)

Screening for Fetal Aneuploidy (Practice Bulletin No. 163)

Prenatal Diagnostic Testing for Genetic Disorders (Practice Bulletin No. 162)

Hereditary Breast and Ovarian Cancer Syndrome (Practice Bulletin No. 103)

Lynch Syndrome (Practice Bulletin No. 147)

The Importance of Preconception Care in the Continuum of Women's Health Care (Committee Opinion No. 313)

Perinatal Risks Associated With Assisted Reproductive Technology (Committee Opinion No. 324)

Using Preimplantation Embryos for Research (Committee Opinion No. 347)

Direct-to-Consumer Marketing of Genetic Testing (Committee Opinion No. 409)

Ethical Issues in Genetic Testing (Committee Opinion No. 410)

Family History as a Risk Assessment Tool (Committee Opinion No. 478)

Pharmacogenetics (Committee Opinion No. 488)

Personalized Genomic Testing for Disease Risk (Committee Opinion No. 527)

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis (Committee Opinion No. 581)

Newborn Screening and the Role of the Obstetrician-Gynecologist (Committee Opinion No. 616)

Hereditary Cancer Syndromes and Risk Assessment (Committee Opinion No. 634)

Cell-free DNA Screening for Fetal Aneuploidy (Committee Opinion No. 640)

Identification and Referral of Maternal Genetic Conditions in Pregnancy (Committee Opinion No. 643)

 




Editor
Russell R. Snyder, MD

Associate Editor
Gretchen M. Lentz, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year